WO2002020017A3 - Verwendung von ectoin oder ectoin-derivaten zur stabilisierung von p53 - Google Patents
Verwendung von ectoin oder ectoin-derivaten zur stabilisierung von p53 Download PDFInfo
- Publication number
- WO2002020017A3 WO2002020017A3 PCT/EP2001/009670 EP0109670W WO0220017A3 WO 2002020017 A3 WO2002020017 A3 WO 2002020017A3 EP 0109670 W EP0109670 W EP 0109670W WO 0220017 A3 WO0220017 A3 WO 0220017A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- ectoin
- radical
- stabilizing
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002524501A JP2004508332A (ja) | 2000-09-04 | 2001-08-21 | p53の安定化におけるエクトインまたはエクトイン誘導体の使用 |
EP01962962A EP1315498A2 (de) | 2000-09-04 | 2001-08-21 | Verwendung von ectoin oder ectoin-derivaten zur stabilisierung von p53 |
AU2001284028A AU2001284028A1 (en) | 2000-09-04 | 2001-08-21 | Use of ectoin or ectoin derivatives for stabilizing p53 |
US10/363,469 US20030199446A1 (en) | 2000-09-04 | 2001-08-21 | Use of ectoin or ectoin derivatives for stabilizing p53 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10043456A DE10043456A1 (de) | 2000-09-04 | 2000-09-04 | Verwendung von Ectoin oder Ectoin-Derivaten zur Stabilisierung von p53 |
DE10043456.8 | 2000-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020017A2 WO2002020017A2 (de) | 2002-03-14 |
WO2002020017A3 true WO2002020017A3 (de) | 2003-03-13 |
Family
ID=7654866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/009670 WO2002020017A2 (de) | 2000-09-04 | 2001-08-21 | Verwendung von ectoin oder ectoin-derivaten zur stabilisierung von p53 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030199446A1 (de) |
EP (1) | EP1315498A2 (de) |
JP (1) | JP2004508332A (de) |
AU (1) | AU2001284028A1 (de) |
DE (1) | DE10043456A1 (de) |
WO (1) | WO2002020017A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1414846A2 (de) * | 2001-08-10 | 2004-05-06 | Medical Research Council | P53-stabilisierendes peptid |
DE10214257A1 (de) * | 2002-03-28 | 2003-10-16 | Merck Patent Gmbh | Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden |
TWI280136B (en) * | 2003-05-30 | 2007-05-01 | Lytone Enterprise Inc | Composition containing dipeptide of histidine and alanine for reducing uric acid |
US7425638B2 (en) | 2003-06-17 | 2008-09-16 | Hoffmann-La Roche Inc. | Cis-imidazolines |
RU2319696C2 (ru) * | 2003-06-17 | 2008-03-20 | Ф.Хоффманн-Ля Рош Аг | Цис-2, 4, 5-триарил-имидазолины |
RU2418633C2 (ru) | 2004-04-08 | 2011-05-20 | Байоматрика, Инк. | Объединение процессов хранения образцов и управление образцами в медико-биологических науках |
US20080176209A1 (en) * | 2004-04-08 | 2008-07-24 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20060286050A1 (en) * | 2005-06-01 | 2006-12-21 | L'oreal | Moisturizing lipstick compositions |
US8519125B2 (en) * | 2009-05-11 | 2013-08-27 | Biomatrica, Inc. | Compositions and methods for biological sample storage |
EP2598660B1 (de) | 2010-07-26 | 2017-03-15 | Biomatrica, INC. | Zusammensetzungen zur stabilisierung von dna, rna und proteinen in blut- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen |
EP2598661B1 (de) | 2010-07-26 | 2017-09-27 | Biomatrica, INC. | Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
WO2015191632A1 (en) | 2014-06-10 | 2015-12-17 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
CN113588501A (zh) | 2015-12-08 | 2021-11-02 | 生物马特里卡公司 | 降低红细胞沉降速率 |
US11304968B2 (en) | 2018-11-16 | 2022-04-19 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide |
US10639294B2 (en) | 2018-10-02 | 2020-05-05 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553884A1 (de) * | 1992-01-30 | 1993-08-04 | Yeda Research And Development Co. Ltd. | Gereinigte Tetrahydropyrimidinderivate und diese enthaltende pharmazeutische Zusammensetzungen |
JPH09143167A (ja) * | 1995-11-17 | 1997-06-03 | Dainippon Pharmaceut Co Ltd | 酵素の安定化法 |
DE19933460A1 (de) * | 1998-07-10 | 2000-01-13 | Beiersdorf Ag | Verwendung von Ectoinen und sulfonierten UV-Filtern |
WO2000007558A1 (de) * | 1998-08-01 | 2000-02-17 | Merck Patent Gmbh | Verwendung von ectoin oder ectoin-derivaten in kosmetischen formulierungen |
WO2000076528A2 (de) * | 1999-06-12 | 2000-12-21 | Bitop Gmbh | Proteinenthaltende pharmazeutische zubereitung |
WO2001058446A1 (de) * | 2000-02-14 | 2001-08-16 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von kompatiblen soluten als inhibitoren des enzymatischen abbaus von makromolekularen biopolymeren |
DE10006578A1 (de) * | 2000-02-14 | 2001-08-23 | Bitop Gmbh | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
WO2001072263A2 (de) * | 2000-03-24 | 2001-10-04 | Merck Patent Gmbh | Verwendung von ectoin oder ectoin-derivaten zum schutz der stressprotein in der haut |
-
2000
- 2000-09-04 DE DE10043456A patent/DE10043456A1/de not_active Withdrawn
-
2001
- 2001-08-21 EP EP01962962A patent/EP1315498A2/de not_active Withdrawn
- 2001-08-21 JP JP2002524501A patent/JP2004508332A/ja not_active Withdrawn
- 2001-08-21 WO PCT/EP2001/009670 patent/WO2002020017A2/de not_active Application Discontinuation
- 2001-08-21 US US10/363,469 patent/US20030199446A1/en not_active Abandoned
- 2001-08-21 AU AU2001284028A patent/AU2001284028A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553884A1 (de) * | 1992-01-30 | 1993-08-04 | Yeda Research And Development Co. Ltd. | Gereinigte Tetrahydropyrimidinderivate und diese enthaltende pharmazeutische Zusammensetzungen |
JPH09143167A (ja) * | 1995-11-17 | 1997-06-03 | Dainippon Pharmaceut Co Ltd | 酵素の安定化法 |
DE19933460A1 (de) * | 1998-07-10 | 2000-01-13 | Beiersdorf Ag | Verwendung von Ectoinen und sulfonierten UV-Filtern |
WO2000007558A1 (de) * | 1998-08-01 | 2000-02-17 | Merck Patent Gmbh | Verwendung von ectoin oder ectoin-derivaten in kosmetischen formulierungen |
WO2000076528A2 (de) * | 1999-06-12 | 2000-12-21 | Bitop Gmbh | Proteinenthaltende pharmazeutische zubereitung |
WO2001058446A1 (de) * | 2000-02-14 | 2001-08-16 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von kompatiblen soluten als inhibitoren des enzymatischen abbaus von makromolekularen biopolymeren |
DE10006578A1 (de) * | 2000-02-14 | 2001-08-23 | Bitop Gmbh | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
WO2001072263A2 (de) * | 2000-03-24 | 2001-10-04 | Merck Patent Gmbh | Verwendung von ectoin oder ectoin-derivaten zum schutz der stressprotein in der haut |
Non-Patent Citations (6)
Title |
---|
ADAMS, J. L. ET AL.: "cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one, a potent inhibitor of mammalian dihydroorotase", J. MED. CHEM., vol. 31, no. 7, 1988, pages 1355 - 1359, XP001074178 * |
BEYER, N. ET AL: "Ectoin - a innovative, multi-functional active substance for the cosmetic industry", SOFW JOURNAL (2000), 126(12), 26,28-29, XP001041687 * |
BUENGER J: "NEUE WIRKSTOFFKLASSE SCHUETZT UND PFLEGT DIE HAUT. ECTOINE STABILISIEREN BIOPOLYMERSTRUKTUREN", PARFUMERIE UND KOSMETIK, HUETHIG, HEIDELBERG, DE, vol. 79, no. 11, 1998, pages 32 - 34-35, XP000852629, ISSN: 0031-1952 * |
DATABASE WPI Section Ch Week 199732, Derwent World Patents Index; Class B04, AN 1997-347460, XP002214202 * |
KREZEL, I: "Antitumor activity of new derivatives of 1,3-diazaheterocycles", PHARMAZIE, vol. 53, no. 9, 1998, pages 614 - 617, XP001074183 * |
SAUER T ET AL: "ECTOINE - BIOTECHNISCHE PRODUKTION UND MOEGLICHE ANWENDUNGSBEREICHE", GIT FACHZEITSCHRIFT FUER DAS LABORATORIUM, DARMSTADT, DE, vol. 39, no. 10, 1995, pages 892 - 896, XP000918716, ISSN: 0016-3538 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001284028A1 (en) | 2002-03-22 |
EP1315498A2 (de) | 2003-06-04 |
US20030199446A1 (en) | 2003-10-23 |
WO2002020017A2 (de) | 2002-03-14 |
DE10043456A1 (de) | 2002-03-14 |
JP2004508332A (ja) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002020017A3 (de) | Verwendung von ectoin oder ectoin-derivaten zur stabilisierung von p53 | |
CA2368095A1 (en) | Process for preparing inhibitors of nucleoside metabolism | |
MXPA02003203A (es) | Composiciones terapeuticas solubles en tocol. | |
MY132671A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
WO2001017972A3 (de) | Neue herbizide | |
BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
WO1999039740A3 (en) | Sensitizing cells to compounds using lipid-mediated gene and compound delivery | |
AU2002211216A1 (en) | Substituted aminopropoxyaryl derivatives useful as agonists for lxr | |
CA2475113A1 (en) | Isothiazole derivatives useful as anticancer agents | |
WO2001017973A3 (de) | Neue herbizide | |
MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
CA2356300A1 (en) | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy | |
CA2496623A1 (en) | Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives | |
WO2001072263A3 (de) | Verwendung von ectoin oder ectoin-derivaten zum schutz der stressprotein in der haut | |
TR200400003T4 (tr) | (S)-2-Ethoxy -3-4-(2-4-Methanesulfonyloxyphenyl ethoxy) propanoic asidin birleştirilmiş hali | |
AP2000001900A0 (en) | Halogeneted amidino amino acid derivatives useful as nitric oxide synthase inhibitors. | |
AU6797298A (en) | Halo-alkoxycarbonyl prodrugs | |
MY138826A (en) | 2,7-substituted indoles | |
BG104447A (en) | Biphenylamidine derivatives | |
BG103778A (en) | Process for preparing pyrazole derivatives | |
CA2317604A1 (en) | Matrix metalloprotease inhibitors | |
UA66866C2 (uk) | Синтез морфолінових похідних | |
TR200200745T2 (tr) | Fenilasetik asit türevleri için proses. | |
MXPA04005210A (es) | Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros. | |
EP1043311A4 (de) | Biphenylamidin-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002524501 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10363469 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001962962 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001962962 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001962962 Country of ref document: EP |